Morton F Goldberg Selected Research

Hyphema

1/2020	Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute.
1/2019	Medical interventions for traumatic hyphema.
12/2013	Medical interventions for traumatic hyphema.
1/2011	Medical interventions for traumatic hyphema.
11/2003	A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Morton F Goldberg Research Topics

Disease

6	Choroidal Neovascularization 08/2013 - 02/2002
5	Hyphema 01/2020 - 11/2003
4	Macular Degeneration (Age-Related Maculopathy) 01/2007 - 02/2002
3	Retinal Neovascularization 01/2022 - 12/2016
3	Nausea 01/2019 - 01/2011
3	Optic Atrophy 01/2019 - 01/2011
3	Hemorrhage 01/2019 - 01/2011
3	Vomiting 01/2019 - 01/2011
3	Incontinentia Pigmenti (Bloch Sulzberger Syndrome) 01/2018 - 05/2008
3	Retinal Detachment (Retinal Detachments) 05/2015 - 01/2007
3	Vascular Remodeling 01/2008 - 10/2004
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2017 - 01/2005
2	Sickle Cell Anemia (Hemoglobin S Disease) 01/2017 - 12/2016
2	Retinal Diseases 01/2017 - 12/2015
2	Ischemia 12/2016 - 01/2016
2	Hypoxia (Hypoxemia) 12/2016 - 09/2005
2	Atrophy 01/2016 - 05/2008
1	Hemoglobin SC Disease (Disease, Hemoglobin SC) 01/2021
1	Hemoglobinopathies 01/2021
1	Vitreoretinochoroidopathy 04/2018
1	Vascular Diseases (Vascular Disease) 01/2017
1	White Dot Syndromes 01/2017
1	Blindness (Hysterical Blindness) 01/2017
1	Persistent Hyperplastic Primary Vitreous 01/2016
1	Seizures (Absence Seizure) 01/2015
1	Brain Diseases (Brain Disorder) 01/2015
1	Blister (Bulla) 01/2015
1	Neoplasms (Cancer) 08/2013
1	Retinal cone dystrophy 2 01/2011
1	Mevalonate Kinase Deficiency 01/2010
1	Adenocarcinoma 01/2010
1	Geographic Atrophy 10/2009
1	Hypertrophy 03/2009
1	Proliferative Vitreoretinopathy 05/2008
1	Retinoschisis (Retinoschisis, Juvenile) 05/2008
1	Retinal Perforations 05/2008
1	Endophthalmitis (Ophthalmia) 01/2007
1	Microphthalmos 03/2005
1	Diabetes Mellitus 01/2005
1	Knobloch syndrome 10/2004
1	Shaken Baby Syndrome 07/2004
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 05/2003
1	Cytochrome-c Oxidase Deficiency 05/2003
1	MERRF Syndrome (Myoclonic Epilepsy and Ragged Red Fibers) 05/2003
1	Kearns-Sayre Syndrome 05/2003

Drug/Important Bio-Agent (IBA)

12	Retinaldehyde (Retinal)IBA 01/2021 - 07/2004
4	Pharmaceutical PreparationsIBA 01/2019 - 01/2007
4	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 01/2019 - 11/2003
3	AcidsIBA 01/2019 - 01/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2011
3	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2019 - 01/2011
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 01/2011
3	Tranexamic Acid (AMCA)FDA Link 01/2019 - 01/2011
3	Mydriatics (Cycloplegics)IBA 01/2019 - 01/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 09/2005
3	Crystallins (Crystallin)IBA 01/2016 - 09/2005
3	anecortave acetateIBA 01/2007 - 02/2003
2	Angiogenesis InhibitorsIBA 12/2003 - 02/2003
1	Sickle HemoglobinIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	BestrophinsIBA 04/2018
1	Adenosine Monophosphate (AMP)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	AngiopoietinsIBA 01/2017
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2017
1	Hypoxia-Inducible Factor 1IBA 01/2017
1	Fluorescein (Funduscein)FDA LinkGeneric 05/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015
1	GlucocorticoidsIBA 01/2015
1	Amino Acids FDA Link 01/2011
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2010
1	CholesterolIBA 01/2010
1	Terpenes (Terpenoids)IBA 01/2010
1	mevalonate kinaseIBA 01/2010
1	Retinal Pigments (Pigments, Visual)IBA 10/2009
1	Phenobarbital (Luminal)FDA Link 03/2009
1	Apyrase (ATP Diphosphatase)IBA 03/2009
1	TrypsinIBA 05/2008
1	3-nitropropionic acidIBA 09/2005
1	gamma-CrystallinsIBA 09/2005
1	EndostatinsIBA 10/2004
1	Verteporfin (Visudyne)FDA Link 08/2004
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 08/2004
1	Adenine FDA LinkGeneric 05/2003
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 05/2003
1	Leu Transfer RNAIBA 05/2003
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 05/2003
1	NucleotidesIBA 05/2003
1	GuanineIBA 05/2003
1	Mitochondrial DNA (mtDNA)IBA 05/2003

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2015
3	Telescopes 01/2019 - 01/2011
3	Bed Rest (Bedrest) 01/2019 - 01/2011
2	Lasers (Laser) 01/2021 - 02/2002
1	Drug Therapy (Chemotherapy) 08/2013
1	Intravitreal Injections 01/2007
1	Photochemotherapy (Photodynamic Therapy) 08/2004